Mineralys Therapeutics, Inc.

MLYSNASDAQ Global Select·USD·Closed

MLYSNASDAQ·USD·Closed

$25.52

−2.56%

$25.52

−$0.67 (2.56%)

52W Range

37thpctl

Volume

0.40×avg

Mkt Cap

2.25BUSD

P/E

-12.8TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

37thpctl

Volume

0.40×avg

Market Cap

2.25BUSD

P/E Ratio

-12.8TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-26.9%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio44.33×